bay-i 9139 has been researched along with Candidiasis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lefler, E; Stevens, DA | 1 |
1 other study(ies) available for bay-i 9139 and Candidiasis
Article | Year |
---|---|
New azole compounds: vibunazole (Bay n7133) and Bay L9139, compared with ketoconazole in the therapy of systemic candidosis and in pharmacokinetic studies, in mice.
Topics: Animals; Antifungal Agents; Candidiasis; Imidazoles; Ketoconazole; Kinetics; Mice; Triazoles | 1985 |